Search Results - "Findor, A"

Refine Results
  1. 1

    Mucosal Immunity and Primary Biliary Cirrhosis: Presence of Antimitochondrial Antibodies in Urine by Tanaka, Atsushi, Nalbandian, Gregory, Leung, Patrick S.C., Benson, Gordon D., Munoz, Santiago, Findor, Jorge A., Branch, Andrea D., Coppel, Ross L., Ansari, Aftab A., Gershwin, M.Eric

    Published in Hepatology (Baltimore, Md.) (01-11-2000)
    “…We have shown that IgA-class antimitochondrial autoantibodies (AMA) can be detected in the bile and saliva of patients with PBC, suggesting that AMA are…”
    Get full text
    Journal Article
  2. 2

    Familial association in autoimmune liver disease by Findor, Jorge A, Sorda, Juan A, Daruich, Jorge R, Manero, Estela F

    Published in Medicina (Buenos Aires) (2002)
    “…The occurrence of autoimmune liver disease in members of the same family is hardly a frequent observation in clinical practice. In a group of 204 cases of…”
    Get full text
    Journal Article
  3. 3

    Ketoconazole-induced liver damage by Findor, J A, Sorda, J A, Igartua, E B, Avagnina, A

    Published in Medicina (Buenos Aires) (1998)
    “…Five cases (four females, one male) of ketoconazole-related liver damage are presented, two of whom died. All patients received ketoconazole (400 mg/day) for…”
    Get more information
    Journal Article
  4. 4

    Intensive plasmapheresis as an alternative therapy for intractable pruritus of primary biliary cirrhosis by Kohan, A I, Findor, J A, Igartua, E B, Villaravid, N

    Published in Transfusion science (1991)
    “…Primary biliary cirrhosis is a chronic disease of presumed autoimmune etiology, generally associated with other systemic abnormalities such as scleroderma,…”
    Get more information
    Journal Article
  5. 5

    Prevalence of antibodies against hepatitis C virus (anti HCV) in different populations with chronic liver disease using the first generation test by Findor, J A, Silva, M, Medina, M, Bruch Igartúa, E, Sordá, J, Findor, A J, Schiff, E

    “…In order to evaluate the prevalence of antibodies IgG against the virus of hepatitis C (anti HCV) in different forms of chronic liver disease negative for…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study by Brunetto, M R, Oliveri, F, Koehler, M, Zahm, F, Bonino, F

    Published in The Lancet (British edition) (23-05-1998)
    “…There is debate about whether interferon-α treatment lowers the risk of progression to hepatocellular carcinoma in patients with chronic viral hepatitis and…”
    Get full text
    Journal Article
  8. 8

    Prevalence of IgG Anti-HEV in Buenos Aires, a Nonendemic Area for Hepatitis E by Rey, JA, Findor, JA, Daruich, JR, Velazco, CC, Igartua, EB, Schmee, E, Kohan, AI

    Published in Journal of travel medicine (01-06-1997)
    “…Hepatitis E virus (HEV) is the main etiological agent for the enterically transmitted form of non-A, non-B hepatitis (ET-NANB), and is associated with epidemic…”
    Get full text
    Journal Article
  9. 9

    Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses by Liang, T J, Jeffers, L, Reddy, R K, Silva, M O, Cheinquer, H, Findor, A, De Medina, M, Yarbough, P O, Reyes, G R, Schiff, E R

    Published in Gastroenterology (New York, N.Y. 1943) (01-02-1993)
    “…Although non-A, non-B (NANB) viral hepatitis has been implicated as an etiology of fulminant hepatitis, hepatitis C virus (HCV) has not been shown to result in…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Hepatolithiasis and Caroli's disease in Argentina: results of a multicenter study by Guma, C, Viola, C, Apestegui, M, Thomé, U, Tani, D, Kido, N, Yoshida, R, Coconi, J, Wulfson, A, Findor, A

    “…The goal of this study was to determine the prevalence, epidemiology and clinical-therapeutical evolution of hepatolithiasis (HL) in Argentina. With this…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Cholestasis associated with ticlopidine by Díaz Fuenzalida, A, Valdés Socín, H, Laudano, O, Avagnina, A, Findor, J A

    Published in Gastroenterología y hepatología (01-03-1997)
    “…The case of a 56-years-old male with cholestasis associated with ticlopidine is presented. Cholestasis is an infrequent adverse effect of this drug. The…”
    Get more information
    Journal Article
  14. 14

    Distribution of the genotypes of hepatitis C virus in intravenous drug addicts in Argentina by Findor, J A, Sordá, J A, Daruich, J, Bruch Igartua, E, Manero, E, Avagnina, A, Benbassat, D, Rey, J, Nakatsuno, M

    Published in Medicina (Buenos Aires) (1999)
    “…Intravenous drug addiction (IVD) is an unfrequent risk factor in Argentina, representing less than 10% of patients (pts) with chronic HCV infection seen in our…”
    Get more information
    Journal Article
  15. 15

    Non alcoholic steatohepatitis by Manero, E, Findor, J A, Avagnina, A, de Elizalde, S, Elsner, B

    Published in Medicina (Buenos Aires) (1994)
    “…A prospective study of 21 patients with the diagnosis of non-alcoholic steatohepatitis (NASH) was carried out. All patients had hepatomegaly and in 10 (48%)…”
    Get more information
    Journal Article
  16. 16

    Hepatitis B (HBV) and C (HBC) virus infections in Down's syndrome and in neuropsychiatric patients without Down's syndrome by Findor, J A, Sordá, J A, Rey, J, Fernández, J, Kohan, A, Díaz Lestrem, M

    “…Hepatitis B virus (HBV) markers are found with high frequency in immunocompromised individuals. In order to find out if this is also true for the hepatitis C…”
    Get more information
    Journal Article
  17. 17

    Hodgkin's disease developing in the course of a chronic liver disease with ulcerative colitis immunosuppressed with azathioprine by Orbuch, S J, Findor, J A

    “…A case of a 49 year old patient suffering from ulcerative colitis and chronic hepatitis with cirrothic transformation is presented who under prolonged…”
    Get more information
    Journal Article
  18. 18

    Response to Hepatitis A Vaccine in Children after a Single Dose with a Booster Administration 6 Months Later by Findor, JA, Cañero Velasco MC, Mutti, J, Safary, A

    Published in Journal of travel medicine (01-09-1996)
    “…Background: Children are of an age group susceptible to infection by the hepatitis A virus (HAV). Active immunization of children against HAV became reality in…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Acute non-A non-B viral hepatitis by Findor, J A, Lafage, M, Bruch Igartua, E M, Domecq, P, Firpo, A M, Domecq, R B

    “…Thirty-one patients HBs Ag negative seen between january 1978 and june 1980 were studied. Twenty-four of them were males and seven females. Their age ranged…”
    Get more information
    Journal Article